» Articles » PMID: 36074090

The MiR-181 Family Regulates Colonic Inflammation Through Its Activity in the Intestinal Epithelium

Abstract

The intestinal epithelium is a key physical interface that integrates dietary and microbial signals to regulate nutrient uptake and mucosal immune cell function. The transcriptional programs that regulate intestinal epithelial cell (IEC) quiescence, proliferation, and differentiation have been well characterized. However, how gene expression networks critical for IECs are posttranscriptionally regulated during homeostasis or inflammatory disease remains poorly understood. Herein, we show that a conserved family of microRNAs, miR-181, is significantly downregulated in IECs from patients with inflammatory bowel disease and mice with chemical-induced colitis. Strikingly, we showed that miR-181 expression within IECs, but not the hematopoietic system, is required for protection against severe colonic inflammation in response to epithelial injury in mice. Mechanistically, we showed that miR-181 expression increases the proliferative capacity of IECs, likely through the regulation of Wnt signaling, independently of the gut microbiota composition. As epithelial reconstitution is crucial to restore intestinal homeostasis after injury, the miR-181 family represents a potential therapeutic target against severe intestinal inflammation.

Citing Articles

MiRNAs: a new target for Chinese medicine to repair the intestinal barrier in the treatment of ulcerative colitis.

Sun D, Zhang Z, Xue J Front Pharmacol. 2024; 15:1446554.

PMID: 39185319 PMC: 11341499. DOI: 10.3389/fphar.2024.1446554.


Post-transcriptional checkpoints in autoimmunity.

Bechara R, Vagner S, Mariette X Nat Rev Rheumatol. 2023; 19(8):486-502.

PMID: 37311941 DOI: 10.1038/s41584-023-00980-y.


Editorial: The role of MicroRNAs and other non-coding RNAs in gut inflammation and gastrointestinal cancers.

Anbazhagan A, Rawat M Front Mol Biosci. 2023; 10:1173690.

PMID: 37021110 PMC: 10067858. DOI: 10.3389/fmolb.2023.1173690.


New insights into bacterial mechanisms and potential intestinal epithelial cell therapeutic targets of inflammatory bowel disease.

Liang B, Wu C, Wang C, Sun W, Chen W, Hu X Front Microbiol. 2023; 13:1065608.

PMID: 36590401 PMC: 9802581. DOI: 10.3389/fmicb.2022.1065608.

References
1.
Lavelle A, Sokol H . Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2020; 17(4):223-237. DOI: 10.1038/s41575-019-0258-z. View

2.
McCarthy D, Chen Y, Smyth G . Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012; 40(10):4288-97. PMC: 3378882. DOI: 10.1093/nar/gks042. View

3.
Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

4.
Carrella S, Barbato S, DAgostino Y, Salierno F, Manfredi A, Banfi S . TGF-β Controls miR-181/ERK Regulatory Network during Retinal Axon Specification and Growth. PLoS One. 2015; 10(12):e0144129. PMC: 4671616. DOI: 10.1371/journal.pone.0144129. View

5.
Piersma B, Bank R, Boersema M . Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge. Front Med (Lausanne). 2015; 2:59. PMC: 4558529. DOI: 10.3389/fmed.2015.00059. View